Shares of Catalyst Pharmaceuticals fell 4.18% to $3.44 at 15:10 EST on Monday, following yesterday's downward trend. The Nasdaq Stock Market is rising 0.3% to $12,502.20, after two successive sessions in a row of gains, on what at the moment seems, a somewhat positive trend exchanging session today.
Catalyst Pharmaceuticals's last close was $3.59, 53.49% under its 52-week high of $5.28.
Catalyst Pharmaceuticals's Sales
Catalyst Pharmaceuticals's sales growth is 11.6% for the current quarter and 4.6% for the next. The company's growth estimates for the current quarter is 25% and a drop 10% for the next.
Catalyst Pharmaceuticals's Revenue
Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.
Catalyst Pharmaceuticals's Stock Top and Bottom Yearly Value
Catalyst Pharmaceuticals's stock is valued at $3.44 at 15:10 EST, way below its 52-week high of $5.28 and way above its 52-week low of $2.55.